 "AstraZeneca")
Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter.
The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago, it added.
The company's board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.
Shares of AstraZeneca Pharma India closed at Rs 3,364.45 per scrip on BSE, down 1.23 per cent from its previous close.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
